- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 02, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,627 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
FWRY | ج.م5.93 | -2.8% | 2.2% | ج.م20.2b | ج.م7.20 | PE32.7x | E34.8% | n/a | Diversified Financials | ||
FDE | €35.15 | 4.9% | -1.0% | €183.8m | €64.07 | PE23.4x | E37.6% | n/a | Energy | ||
MVW | kr8.35 | 1.8% | 7.3% | kr273.2m | kr13.00 | PS24.8x | E66.8% | n/a | Materials | ||
ELF | US$160.53 | -8.8% | 79.5% | US$8.8b | US$205.92 | PE68.9x | E26.4% | n/a | Household | ||
APLT | US$4.53 | 7.1% | 200.0% | US$507.2m | US$11.60 | PS51.8x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$150.31 | 4.6% | -26.8% | US$19.0b | US$221.12 | PS9.5x | E61.8% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$74.19 | 3.7% | 4.3% | US$3.6b | US$122.69 | PS13x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$23.30 | 4.2% | 252.5% | CA$766.9m | CA$24.61 | PE21.1x | E33.8% | 2.0% | Diversified Financials | ||
RCEL | US$8.72 | 5.1% | -46.1% | US$223.2m | US$25.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$4.75 | 5.1% | -2.7% | US$192.5m | US$19.00 | PS7.2x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$21.94 | -5.3% | 30.1% | US$2.4b | US$25.50 | PE22.9x | E43.0% | 3.6% | Energy | ||
ASND | US$141.10 | 3.0% | 50.1% | US$8.1b | US$177.45 | PS28.2x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
DIRR3 | R$23.85 | -2.0% | 55.0% | R$4.1b | R$29.18 | PE12.4x | E26.1% | 2.0% | Consumer Durables | ||
AVLL3 | R$3.74 | 3.6% | 33.1% | R$730.5m | R$9.90 | PS1.5x | E101.9% | n/a | Consumer Durables | ||
TGTX | US$16.42 | 18.0% | -53.1% | US$2.3b | US$31.38 | PE57.8x | E47.5% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$134.64 | 0.7% | 69.3% | US$40.8b | US$145.80 | PE60.7x | E41.3% | 2.8% | Diversified Financials | ||
NVDA | US$858.17 | -2.2% | 199.2% | US$2.1t | US$1,002.20 | PE71x | E23.4% | 0.02% | Semiconductors | ||
EH | US$18.32 | 0.7% | 64.0% | US$1.1b | US$23.83 | PS71.5x | E97.6% | n/a | Capital Goods | ||
CYC | AU$1.80 | 2.9% | -14.3% | AU$169.5m | AU$4.62 | PS6.2x | E92.8% | 0% | Healthcare | ||
5038 | JP¥1,343.00 | -2.1% | -33.4% | JP¥20.1b | n/a | PE32.8x | E24.7% | n/a | Healthcare | ||
4480 | JP¥3,555.00 | -3.8% | 1.1% | JP¥115.0b | JP¥5,865.00 | PE44.8x | E23.6% | n/a | Healthcare | ||
7373 | JP¥1,688.00 | -2.6% | -38.2% | JP¥25.7b | JP¥4,600.00 | PE22.7x | E28.1% | n/a | Commercial Services | ||
301358 | CN¥35.02 | 8.7% | -11.9% | CN¥26.5b | n/a | PE18.2x | E30.3% | 1.2% | Capital Goods | ||
526 | CN¥64.50 | -0.9% | 207.6% | CN¥7.9b | CN¥63.49 | PE65.7x | E36.9% | n/a | Consumer Services |